摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-nonen-4S-yl 4-O-acetyl-3-O-benzyl-β-D-fucopyranoside | 1130996-48-3

中文名称
——
中文别名
——
英文名称
1-nonen-4S-yl 4-O-acetyl-3-O-benzyl-β-D-fucopyranoside
英文别名
[(2R,3S,4R,5R,6R)-5-hydroxy-2-methyl-6-[(4S)-non-1-en-4-yl]oxy-4-phenylmethoxyoxan-3-yl] acetate
1-nonen-4S-yl 4-O-acetyl-3-O-benzyl-β-D-fucopyranoside化学式
CAS
1130996-48-3
化学式
C24H36O6
mdl
——
分子量
420.546
InChiKey
FTHYCRAZTQSQAF-FMYUWVRYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.6
  • 重原子数:
    30
  • 可旋转键数:
    13
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.62
  • 拓扑面积:
    74.2
  • 氢给体数:
    1
  • 氢受体数:
    6

反应信息

  • 作为反应物:
    描述:
    1-nonen-4S-yl 4-O-acetyl-3-O-benzyl-β-D-fucopyranoside3-O-tert-butyldimethylsilyl-2-O-chloroacetyl-4,6-O-isopropylidene-D-glucopyranose 1-trichloroacetimidate三氟化硼乙醚 作用下, 以 二氯甲烷环己烷 为溶剂, 以52%的产率得到[(4aR,6S,7R,8S,8aR)-6-[(2R,3R,4S,5S,6R)-5-acetyloxy-6-methyl-2-[(4S)-non-1-en-4-yl]oxy-4-phenylmethoxyoxan-3-yl]oxy-8-[tert-butyl(dimethyl)silyl]oxy-2,2-dimethyl-4,4a,6,7,8,8a-hexahydropyrano[3,2-d][1,3]dioxin-7-yl] 2-chloroacetate
    参考文献:
    名称:
    Total Synthesis of Ipomoeassin F
    摘要:
    The first total synthesis of ipomoeassin F was carried out using a convergent approach that relied upon the use of Schmidt glycosidation technology for the coupling of two suitably protected monosaccharide fragments. After two steps, ring-closing metathesis was used to form the macrocyclic ring, and seven more steps then furnished ipomoeassin F. In vitro inhibitory activity against a four-panel cell line showed low nanomolar inhibitory activity.
    DOI:
    10.1021/ol900086b
  • 作为产物:
    描述:
    1-nonen-4S-yl 4-O-acetyl-3-O-benzyl-2-O-tert-butyldimethylsilyl-β-D-fucopyranoside盐酸 作用下, 以 甲醇 为溶剂, 以3.55 g的产率得到1-nonen-4S-yl 4-O-acetyl-3-O-benzyl-β-D-fucopyranoside
    参考文献:
    名称:
    Total Synthesis of Ipomoeassin F
    摘要:
    The first total synthesis of ipomoeassin F was carried out using a convergent approach that relied upon the use of Schmidt glycosidation technology for the coupling of two suitably protected monosaccharide fragments. After two steps, ring-closing metathesis was used to form the macrocyclic ring, and seven more steps then furnished ipomoeassin F. In vitro inhibitory activity against a four-panel cell line showed low nanomolar inhibitory activity.
    DOI:
    10.1021/ol900086b
点击查看最新优质反应信息